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such, they will be useful for the rapidly expanding field of neurological development and disease modeling, high-content
screening, and regenerative therapies based on pluripotent stem cell technology.
© 2013 Elsevier B.V. All rights reserved.IntroductionHuman embryonic stem cells (hESCs) and induced pluripotent
stem cells (iPSCs) have provided a platform for studying basic
human development and disease mechanisms and hold great
potential for future cell therapies (Murry and Keller, 2008).
However, biomedical application of hESCs and iPSCs depends
on the availability of robust cell expansion and differentiation
protocols. Undifferentiated colonies of hESCs and iPSCs can be
technically challenging to maintain and expand. For example,
they thaw from frozen samples with low efficiency and then
require co-culture with mouse embryonic fibroblasts (MEF),
or expensive media and matrix proteins, in order to remain
undifferentiated. Furthermore, they need daily medium
changes, examination, and manual selection to ensure the
cultures remain in an undifferentiated state. Finally, N10%
of hESC and iPSC cultures develop karyotypic anomalies
(Ben-David et al., 2011; Peterson et al., 2011; Taapken
et al., 2011), which should bemonitored as they could impact
differentiation capabilities (Graf and Stadtfeld, 2008) and
clinical applicability. Clearly, less time consuming and labor
intensive culturing techniques would be advantageous.
Research into embryogenesis and nervous system develop-
ment has been instrumental to the identification of factors
required for cell specification. Using information gleaned from
these studies, many groups have developed induction protocols
to instruct hESCs and iPSCs to become a variety of neural cell
types (Zhang et al., 2001), including motor neurons, dopamine
neurons, striatal neurons, and oligodendrocytes (Aubry et al.,
2008; Delli Carri et al., 2013; Li et al., 2005; Nistor et al., 2005;
Perrier et al., 2004). Some of these traditional differentiation
protocols use embryoid body (EB) formation as the first step of
lineage restriction tomimic early human embryogenesis (Zhang
et al., 2001), which is then followed by manual selection of
neuroepithelial precursors. Interestingly, the efficiency of EB
formation and subsequent differentiation can vary among
hESC and iPSC lines, and in some instances fail using the same
culturing conditions (Boulting et al., 2011; Hu et al., 2010;
Osafune et al., 2008). While the mechanisms underlying these
differences remain to be determined, this observation suggests
that progressing through an EB step may not always be optimal.
Additionally, EBs cannot be robustly expanded, so one must
start with a large number of undifferentiated hESCs or iPSCs to
generate enough EBs to push through the various differentia-
tion steps for each experimental or therapeutic use, therefore
increasing batch-to-batch variations among differentiation
procedures.
A technique that efficiently expands neural stem cells from
hESCs or iPSCs and allows consistent differentiation of neural
tissue is of great interest, and there are a number of published
protocols that have been developed (Chaddah et al., 2012;
Elkabetz et al., 2008; Koch et al., 2009; Nemati et al., 2011).
Elkabetz et al. (2008) used an extended EB formation period and
sorting methods to isolate rosette stage neuroepithelial cellsthat allowed them to generate a transient population of
expandable neural stem cells that retain differentiation
potential. In contrast to other reports (Falk et al., 2012;
Koch et al., 2009), only when these cells were grown in the
presence of signaling molecules (e.g. sonic hedgehog and
notch) were they able to retain rosette formation and
structure, induce proliferation, and subsequently differen-
tiate into motor neurons, dopamine neurons, and neural
crest progenitor cells (Elkabetz et al., 2008). However,
further expansion in the presence of growth factors resulted in
the loss of rosette formation and in vitro regionalization
capacity and biased the culture toward gliogenic differentiation
(Elkabetz et al., 2008). Also, Koch et al. (2009) described a
protocol in which neuroepithelial stem cells were mechanically
isolated following EB formation and expanded in the presence
of EGF and FGF-2 to successfully generate a variety of neural
subtypes. However, cells became regionally restricted after
~15 in vitro passages (Falk et al., 2012; Koch et al., 2009).
In the current study we have devised a method that
generates pre-rosette stem cells directly from hESCs and iPSCs
in a free-floating aggregate system in the presence of EGF and
FGF-2. Due to their ease of expansion and differentiation, we
have termed these cultures “EZ spheres”. Using our previously
described method of a mechanical, non-enzymatic chopping
technique (Svendsen et al., 1998), EZ spheres can be
expanded for at least 30 passages while maintaining chromo-
somal stability. Given the proper neural differentiation condi-
tions, rosettes appear within whole spheres and upon plate-
down indicating that EZ spheres retain rosette properties after
long-term exposure to EGF and FGF-2. Longitudinal analysis of
neural gene expression patterns in EGF and FGF-2 culture
conditions showed consistent and sustained expression of
nestin and SOX2 for all lines, with more varied expression of
region specific markers including FOXG1, GBX2, PAX7, and
OTX2. Nevertheless, EZ spheres could be taken at any passage
and placed into appropriate differentiation conditions to
generate specialized neuronal and glial subtypes, such as
dopamine neurons, motor neurons, striatal neurons, periph-
eral sensory neurons, astrocytes, and oligodendrocytes, with
similar efficiencies between hESCs and iPSCs. Importantly, EZ
spheres do not acquire regionally restricted differentiation
potential over successive passages. As a result, the EZ sphere
method eliminates the need for EB formation and manual
selection, allows for exponential expansion of pre-rosette
multipotent neural stem cells, is amenable to healthy and
disease-specific iPSCs, and increases versatility of lineage
specification over other published techniques.Materials and methods
Cell culture
hESCs (H9 WiCell Research Institute) and iPSCs were grown
on irradiated MEF as previously described (Thomson et al.,
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(4.2 line, GM003814 Coriell Institute; 21.8 line, GM002183
Coriell) using previously published protocols (Yu et al., 2007).
EZ sphere generation and passaging
EZ spheres were generated by lifting intact colonies
from MEF feeder layers following collagenase treatment
(1 mg/ml, Gibco) and placing them directly into a human
neural progenitor growth medium (Stemline, Sigma) sup-
plemented with 100 ng/ml basic fibroblast growth factor
(FGF-2, Chemicon), 100 ng/ml epidermal growth factor (EGF,
Chemicon), and 5 μg/ml heparin (Sigma) in ultra-low attach-
ment flasks and were passaged weekly using a chopping
technique (Svendsen et al., 1998).
Cryopreservation
The EZ spheres were settled into a pellet and transferred
from EGF and FGF-2 supplemented media into serum-free,
8.7% DMSO-supplemented cell freezing media (Sigma). The
cryovials were transported to a −80 °C freezer using an
isopropyl alcohol chamber for 24 h. The frozen vials were then
preserved for long-term in standard liquid nitrogen storage
containers.
Karyotyping
EZ spheres were dissociated using TrypLE (Life Technolo-
gies), plated onto matrigel-coated, tissue culture treated
T25 flasks in EGF and FGF-2 supplemented media, and grown
to confluency. Standard G-banding chromosome analysis was
performed by Cell Line Genetics (Madison, WI).
Cell counts
Prior to passaging, a small number of EZ spheres were
dissociated using TrypLE and counted using trypan blue
exclusion with either a glass hemocytometer or the TC-10
Cell Counter (Bio-Rad, Hercules, CA). The projected total
cell number was calculated for each passage based on
expansion data (Fig. 1C).
Differentiation
To induce astrocyte differentiation, spheres were dissociated
with accutase (Chemicon) or TrypLE and plated onto
poly-ornithine/laminin (Sigma) coated coverslips in Stemline
with 2% B27 without growth factors for 2–4 weeks. Terminal
differentiation into dopamine neurons, motor neurons, striatal
neurons, sensory neurons, and oligodendrocytes followed
previously published reports (Aubry et al., 2008; Lee et al.,
2010; Li et al., 2005; Nistor et al., 2005; Schneider et al.,
2007; Zhang et al., 2001). Briefly, spheres were removed
from Stemline/EGF/FGF-2/heparin medium and placed in
the appropriate induction media for terminal differentia-
tion. At appropriate times, spheres were then plated onto
poly-ornithine/laminin coated coverslips in growth factor
supplemented media to achieve terminal differentiation
and mature cell types (Fig. S3).RNA isolation and PCR analysis
Total RNA was isolated using the RNeasy Mini Kit (Qiagen) with
on-column DNase I digestion or Tri-Reagent (Sigma). cDNA was
generated from 1 to 4 μg total RNA using SuperScript III
(Invitrogen). RT-PCR and/or qRT-PCR were performed using
specific primer sequences under standard conditions (Table S3).
Immunocytochemistry
Plated cells and whole spheres were fixed in 4% paraformal-
dehyde for 20 min at room temperature and rinsed with PBS.
Spheres were sectioned at 15 μm using a cryostat and
mounted onto microscope slides. Nonspecific labeling was
blocked and the cells were permeabilized with 5% normal goat
serum and/or 5% normal donkey serum and 0.2% Triton X-100
in PBS for 30 min at room temperature. Cells were rinsed with
PBS and then incubated with primary antibodies (Table S4) for
1 h at room temperature or overnight at 4 °C. Cells were then
labeled with the appropriate fluorescently-tagged secondary
antibodies. Hoechst nuclear dye was used to label nuclei.
Imaging and cell counting analysis
Ten images were taken on at least three different fluores-
cently labeled coverslips per condition on a Leica DM6000B
(Wetzlar, Germany) upright microscope using the LAS Ad-
vanced Fluorescence imaging software (version 2.4.1, Leica,
Wetzlar, Germany). The imageswere then counted for antigen
and Hoechst nuclear dye specificity using MetaMorph Software
(Molecular Devices Inc., Sunnyvale, CA). The counts for each
passage of each cell line were averaged as a single data point
and then the three cell lines were plotted at each passage
(n=3). The data were statistically analyzed via a one-way
ANOVA using a Bonferroni post-hoc test with Prism software
(GraphPad, La Jolla, CA).
Electrophysiology
Whole cell voltage clamp and current clamp recordings were
performed as described previously using an EPC 9 amplifier
(HEKA, Germany) and Pulse software (version 8.78, HEKA,
Lambrecht, Germany) (Dirajlal et al., 2003). Recording
pipettes were pulled from fire-polished borosilicate capillary
tubes (Sutter Instruments, Novato, CA) using a Flaming-Brown
micropipette puller (Model P97, Sutter Instruments, Novato,
CA). Pipette resistances ranged from 3 to 7 MΩ. Electrodes
were back-filled with an intracellular buffer consisting of
(in mM): KCl, 135; HEPES, 10; EGTA, 2; MgCl2, 4.1; ATP, 2.5;
GTP, 0.2; pH 7.2 (titrated with KOH); osmolality=290±3 mosM
(adjusted with sucrose). Extracellular buffer consisted of
(in mM): NaCl, 140; KCl, 5; CaCl2, 2; MgCl2, 1; HEPES, 10;
glucose, 10; pH 7.4 (titrated with NaOH); osmolality=310±
3 mosM. Putative astrocytes were targeted and identified
based on morphology and lack of action potential generation.
Current–voltage relationships were examined in voltage clamp
mode by holding the cell membrane at a resting potential of
−70 mV and then sequentially clamping the cell membrane
for 100 ms at potentials ranging from −160 mV to +20 mV in
10 mV steps.
Fig. 1 EZ spheres show stable growth over time. (A) Human 21.8 iPSC derived embryoid bodies displayed a fragmented and
unhealthy appearance compared to (B) EZ spheres, which exhibited round, tightly packed aggregates. (C) All three EZ sphere lines
showed similar expansion rates. The dip in expansion for 4.2 iPSC EZ spheres at passage 15 is attributed to changes in the growth
medium lot, but they quickly recovered and were not significantly different by passage 28. (D) Cryosectioned 4.2 iPSC EZ spheres
contain Ki67 positive proliferating cells. (E) Quantification of Ki67 immunofluorescent cells from all three EZ sphere lines shows
consistent proliferation over time.
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There are a number of complex methods for the generation
of neural subtypes from hESCs and iPSCs. In most of them,
intact pluripotent colonies are first lifted, induced to form
EBs, and then grown in the presence of lineage specific
morphogens and growth factors to produce a variety of
terminally differentiated neurons (dopamine, cholinergic,
etc.), astrocytes, and oligodendrocytes (Murry and Keller,
2008). Although successful, this technique was not efficient
for all iPSCs. For example, although all iPSCs generated
EBs, over 50% of the EBs derived from both healthy and
diseased iPSCs displayed an unhealthy appearance, such as
tattered edges, fragmented and irregular shapes, mem-
brane blebbing, and dark coloring, and did not efficiently
survive neural specification (Fig. 1A). We therefore devel-
oped EZ spheres as an alternative to EB formation to
consistently transition iPSCs from undifferentiated colonies
to differentiated neural subtypes. Furthermore, in order to
avoid potential bias in long-term differentiation potential,
as shown in previously published protocols (Elkabetz et al.,
2008; Koch et al., 2009; Nemati et al., 2011), we aimed to
generate an expandable pre-rosette population of neural stem
cells that could retain greater plasticity upon differentiation.
EZ spheres were generated by gently lifting the
undifferentiated colonies from MEFs or Matrigel using
enzymatic dissociation (e.g. collagenase, dispase), tech-
niques consistent with EB generation protocols. Clumps of
cells were then placed in ultra-low attachment flasks in
neural progenitor cell medium consisting of 100 ng/ml EGF,
100 ng/ml FGF-2 (human or zebrafish), and 5 μg/ml heparin;the high level of EGF has previously been shown to increase
the proliferation and neuronal potential of human fetal neural
progenitor cells (Nelson et al., 2008). In this medium, the cells
clustered into tightly compacted spheres with regular edges
and a golden color within 3–5 days (Fig. 1B). EZ spheres
continued to expand (many cultured for over a year), were
passaged weekly by mechanical chopping, and could be
cryopreserved and subsequently thawed with high efficien-
cy. Cells within EZ spheres doubled in number every 7 days
with approximately 20% of cells undergoing active prolifer-
ation at any one time based on Ki67 labeling (Figs. 1C–E).
They also showed chromosomal stability for at least 30
passages (latest passage assessed) (Fig. S1).
We have produced and expanded EZ spheres from 19
independent hESC and iPSC lines, including healthy and
disease-specific lines generated through multiple repro-
gramming methods, all of which demonstrates the robustness
of the method (Table S1). In order to better characterize the
composition and stability of EZ spheres, we undertook a
systematic and longitudinal assessment using EZ spheres
derived from H9 hESCs (Thomson et al., 1998) and two
independent unaffected iPSC lines (Coriell fibroblast line
GM003814 (4.2 iPSC), Coriell fibroblast line GM002183 (21.8
iPSC)). These iPSC lines have each been previously charac-
terized for full reprogramming and down-regulation of
exogenous transgene expression (Ebert et al., 2009; HD
iPSC Consortium, 2012). First, EZ spheres were analyzed for
various pluripotency and neural progenitor markers at 0, 2,
4, 8, 15, 20, and 28 passages post-sphere formation by
immunocytochemistry. Specifically, we found that nearly
75% of cells derived from all three stem cell lines were
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lowing sphere formation (passage 0), but this dramatically
decreased by passage 2 and was virtually absent in subsequent
passages (Fig. 2A). Further, immunocytochemical analysis of
dissociated EZ spheres showed that there was a significant
increase in nestin expression after passage 2, such that N60%
of cells were nestin positive after passage 4 and N90% of cells
by passage 7 (Fig. 2B). Next, immunocytochemistry of intact
EZ spheres showed expression of neural progenitor and radial
glial markers such as nestin, PAX6, vimentin, BLBP, SOX1, and
SOX2 throughout the spheres, but limited expression of the
motor neuron and/or oligodendrocyte progenitor marker
OLIG2, the mature neuronal marker MAP2, or pluripotency
markers Nanog, SSEA3, and Tra-1-81 (Fig. 2C).
As a first step to assess the cellular composition in EZ
spheres, we performed PCR analysis for a variety of pluripo-
tent and region specific markers (Fig. 3A). At passage 12, 21.8
iPSC-derived EZ spheres showed expression of a number of
early neural progenitor (nestin, SOX1, Dach1) and posterior
markers (HOXB4, GBX2), but limited expression of more
anterior markers (FOXG1, OTX2) suggesting EZ spheres may
also undergo regional specification during extended culturing
as has been shown by others (Elkabetz et al., 2008; Koch et al.,
2009). To more thoroughly assess this question, we examined
gene expression by PCR at every passage out to 32 using a set
of regional identity markers: neural ectoderm (SOX2, nestin,
PAX6), anterior (FOXG1, OTX2), posterior (GBX2), dorsal
(PAX7), neural crest (HNK1), and undifferentiated stem cells
(OCT4). Representative PCR gels for undifferentiated colonies
and EZ spheres at passages 0, 9, 18, and 27 (Fig. 3B) show basal
expression levels among the lines and passages (a compiled
table indicating relative expression at all passages is presented
in Table S2). OCT4 expression was detected only in early
passages and was silenced in all lines consistent with the
immunocytochemistry results (Figs. 2A, 3B). Nestin, SOX2, and
HNK1were consistently expressed in all three lines through late
passages, indicating maintenance of a neural progenitor cell
population amenable to both central and peripheral nervous
system subtypes (Fig. 3B, Table S2). Nestin was detected in
undifferentiated colonies in all lines, which is consistent with
previously reported data (Keil et al., 2012). PCR analysis for
region specific markers showed fluctuations in gene expression
levels over successive passages while maintained in EGF/FGF-2
growth conditions. For example, OTX2 was expressed at high
levels in nearly every passage of H9 hESC- and 4.2 iPSC-derived
EZ spheres, but not in 21.8 iPSC-derived EZ spheres (Fig. 3B,
Table S2). On the other hand, PAX6, PAX7, FOXG1, and GBX2
were detected only sporadically at early and late passages in all
lines (Fig. 3B, Table S2). Taken together, these data highlight
that EZ spheres maintained long-term in EGF and FGF-2 are
dynamic across passages, but that there is not a selective
growth advantage for one regional progenitor cell over
another. Additionally, gene expression patterns appear to
be influenced by inherent properties of each cell line, similar
to previously reported results (Boulting et al., 2011), rather
than the culture conditions.
Columnar neuroepithelial-like cells identified within
rosette structures are a hallmark of neural progenitor cells
and are found transiently in EBs or monolayer differenti-
ation protocols during lineage restriction of hESCs toward
neural subtypes (Chambers et al., 2009; Zhang et al.,
2001). We therefore tested whether cells in EZ sphereswere representative of a pre-rosette neural stem cell
population that could be extensively expanded. We examined
rosette markers by immunocytochemistry using intact spheres
at multiple EZ sphere passages (13, 16, 21, and 28). Sections
through 21.8 iPSC EZ spheres grown in EGF and FGF-2 did not
reveal immunolabeling for PLZF, ZO-1, or N-cadherin (Figs. 4A,
B), which are all standard markers used to identify the apical
orientation of rosettes (Abranches et al., 2009). However,
following 7 days of neural induction initiated by removing EGF
and FGF-2 and supplementing with N2 and BDNF, rosettes
characterized by a central lumen and radially disposed
neuroepithelial cells appeared and robustly expressed PLZF in
conjunctionwith apical rosettemarkers ZO-1, PAR3,β-catenin,
and N-cadherin (Figs. 4C–J). Importantly, rosettes were also
detected in whole sections through 4.2 iPSC EZ spheres as well
as upon plate-down of H9 hESC EZ spheres following 1 week of
neural differentiation (Fig. S2). These data indicate that neural
stem cells within EZ spheres are captured in a self-renewing,
pre-rosette stage, which precedes the long-term neural stem
cell (LT-hESNSC) stage described by Koch and colleagues (Koch
et al., 2009).
We next aimed to test the differentiation capabilities of
the EZ spheres. We found that at any passage for all cell lines
regardless of cryopreservation, EZ spheres can be placed in
specific neural induction media for terminal neuronal or glial
cell differentiation using protocols adapted from those
reported previously (Aubry et al., 2008; Lee et al., 2010; Li
et al., 2005; Nistor et al., 2005; Schneider et al., 2007; Zhang
et al., 2001) (Fig. S3). Methods in which EB formation is the
initial step in differentiation, EZ spheres were substituted for
EBs. Using the EZ sphere technique for both hESCs and iPSCs,
we show the generation of various neuronal cells (Fig. 5A),
including dopamine neurons (Fig. 5B), motor neurons
(Fig. 5C), striatal neurons (Fig. 5D), neural crest progenitor
cells (Fig. 5E), and peripheral sensory neurons (Fig. 5F).Using
glial differentiation protocols (Fig. 5G), we were able to
generate oligodendrocytes and astrocytes from EZ spheres.
Importantly, we have previously shown that neurons derived
from EZ spheres are electrophysiologically active (HD iPSC
Consortium, 2012). Similarly, EZ sphere derived astrocytes
express typical potassium channel properties (Fig. S4).
Differentiations presented in Fig. 5 are from passages ranging
from 5 to 36 with no variation in differentiation efficiency
(data not shown). Previous studies have demonstrated
increased neural differentiation following inhibition of
TGFβ, activin, and BMP (Chambers et al., 2009). We therefore
tested whether this dual SMAD inhibition would increase
nestin expression in p3 H9 hESC EZ spheres. However, we
found no difference in nestin expression between treated and
untreated EZ spheres using both immunocytochemistry and
PCR (Fig. S5).
Finally, we wanted to directly compare the differentia-
tion efficiency between the traditional EB method and the
EZ sphere method. Using H9 hESCs, we performed simulta-
neous directed differentiation toward tyrosine hydroxylase
(TH) positive neurons by exposing EB and EZ spheres to FGF-8
and sonic hedgehog as described previously (Schneider
et al., 2007). Importantly, EZ spheres do not generate TH
dopamine neurons when cultured only in the presence of
EGF and FGF-2 (Fig. 6B). However, treatment of floating EZ
spheres with FGF-8 for two weeks, FGF-8 and sonic
hedgehog for one week, and maturation of plated cells in
Fig. 2 EZ spheres rapidly up-regulate neural progenitor markers. (A) Combined data from dissociated cells from the three EZ sphere
lines showed nearly immediate decline in the pluripotency marker OCT4 and (B) a corresponding increase in the neural progenitor
marker nestin. (C) Immunocytochemistry for a variety of pluripotency and lineage markers was performed on cryosectioned whole
21.8 iPSC EZ spheres at passage 13. The pluripotency markers TRA-1-81, Nanog, and SSEA-3 were absent in the spheres, whereas
neural progenitor markers nestin, PAX6, SOX2, and SOX1 were readily expressed. Additional radial glial markers vimentin and BLBP
and the glutamate transporter GLAST were highly expressed in EZ spheres, although the motor neuron/oligodendrocytes progenitor
marker OLIG2 and the mature neuron marker MAP2 were nearly absent. **pb0.001; ***pb0.0001.
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Fig. 3 Longitudinal gene expression highlights dynamic properties of EZ spheres. (A) Passage 13 EZ spheres from 21.8 iPSCs showed high
expression of neural progenitor markers and posterior markers, but no expression of anterior forebrain markers. Actin was used for a
control. (B) Longitudinal PCR analysis for regional markers across multiple passages showed both up-regulated and down-regulated
expression of region-specific genes over time. GAPDH was used as a control.
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TH/Tuj1 double positive neurons in equal numbers to those
generated using the EB dopamine neuron differentiation
method (Figs. 6A, B). In all the differentiations we have
attempted thus far using EZ spheres, efficiencies are
comparable to standard EB differentiation protocols
reported in the literature, they proceed through a similar
time line as neural cells derived using traditional EB
methods, and display up-regulation of appropriate tran-
scription factors and markers as would be indicative of
regional specification for a particular neural cell type. For
example, the ventral hindbrain/spinal cord markers ISLET1
and HB9 were detected in EZ sphere cultures undergoing
motor neuron differentiation (Fig. 5C). Similarly, prior to the
generation of peripherin positive sensory neurons, neural crest
markers AP2 and p75were significantly up-regulated indicating
the appropriate lineage restriction process is followed
(Fig. 5E). The anterior forebrain markers OTX2 and FOXG1
were highly expressed as early as 7 days following transition
into the striatal differentiation conditions using 21.8 iPSC EZ
spheres (Fig. S6). This is particularly important because
21.8 iPSC EZ spheres did not show expression of OTX2 and
FOXG1 while expanded in EGF and FGF-2 (Fig. 3B, Table S2).
Finally, during glial differentiation we detected increased
expression of progenitor and more mature markers including
NG2, PDGFRα, S100, and ALDH1L1 (data not shown). Taken
together, these data highlight that EZ spheres expanded in EGF
and FGF-2 maintain multipotent neural stem cells responsive
to multiple regional cues that generate differentiated cell
types in equivalent efficiencies to more complex methods.Discussion
Generating neural stem cells from hESCs and iPSCs has been
successfully achieved by a number of groups (Elkabetz et al.,
2008; Falk et al., 2012; Koch et al., 2009; Nemati et al., 2011).
However, the simplicity and retained – or even enhanced –
differentiation versatility combined with economical aspects
of their growth (e.g.minimalmedium components and reduced
hands-on maintenance) are distinct advantages of the EZ
sphere method over other published protocols. EZ spheres
also recover from cryostorage with high efficiency, thus
facilitating experimental use.
EZ spheres do not require EB formation or manual selection
processes, yet they still can be efficiently patterned into a
variety of neural subtypes without acquiring regional differ-
entiation bias over time, an advantage over other published
protocols (Falk et al., 2012; Koch et al., 2009; Nemati et al.,
2011). Moreover, properly organized rosette structures can be
generated even after long-term culture in EGF and FGF-2.
Because EZ spheres are captured prior to rosette formation,
they do not show rosette markers without neural induction
(Fig. 4). This suggests that EZ spheres expand the earliest
neural stem cell population so far identified, which can be
positioned at a pre-rosette stage and before LT-hESNSCs
(Koch et al., 2009), therefore bearing greater flexibility in
terms of terminal differentiation. Although selecting pre-
formed rosettes increases the purity of the differentiated
neural cultures, this may also be limiting their differenti-
ation potential as previous work has shown that hESC-derived
neural progenitor cells are restricted by the time SOX1 is
Fig. 4 EZ spheres can generate well-formed rosettes. (A, B) Immunocytochemistry of whole cryosectioned 21.8 iPSC EZ spheres
showed no rosette formation in the absence of neural induction. In contrast, after 7 days of neural induction EZ spheres exhibited
expression of the rosette markers (C–E) N-cadherin, (E–H) ZO-1, (F–H) PLZF, (I) β-catenin, and (J) PAR3. Passage number and marker
used are indicated.
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Fig. 5 Upon directed differentiation, EZ spheres readily produce cells within the neural lineage. Immunocytochemical staining of
various lineage markers showed that EZ spheres could generate (A) TuJ1, NF160, and MAP2a/b positive neurons, (B) TH positive
dopamine neurons, (C) HB9, ISLET1, SMI32R, and ChAT positive motor neurons, (D) DARPP32, GABA, calbindin and calretinin positive
striatal neurons, (E) AP2 and p75 positive neural crest progenitor cells, and (F) peripherin positive sensory neurons. (G) EZ spheres
could also generate cells of glial lineage, including O4 positive immature oligodendrocytes and GFAP positive astrocytes. Nuclei are
labeled with Hoechst in blue. A and D are from 21.8 iPSC EZ spheres; B, E, and F are from H9 hESC EZ spheres; C and G are from 4.2
iPSC EZ spheres.
425EZ spheres: Culture system of multipotent stem cells from human ESCs and iPSCsexpressed in well formed rosettes (Li et al., 2005). It may
also be possible that retaining non-neurally committed
cell types in the spheres exposes the cells to signaling
processes more consistent with in vivo development including
early instruction from mesoderm (Lumsden and Krumlauf,
1996). EZ spheres express themesodermalmarker Brachyury as
well as the endodermal marker alpha fetoprotein (data
not shown), which may be contributing to the diverse
differentiation potential. However, EZ spheres are not
simply fully undifferentiated stem cells grown in suspen-
sion culture similar to those described by Steiner et al. (2010).
OCT4, Nanog, SSEA3, and Tra-1-81 expression were significantly
down-regulated in EZ spheres almost immediately after sphere
formation (Fig. 2) indicating that EGF and FGF-2 in combina-
tion are not capable of maintaining a large population of
undifferentiated stem cells in suspension.Our longitudinal examination of neural gene expression by
PCR showed that EGF and FGF-2 maintain a heterogeneous
population of cells within the spheres. Although central and
peripheral neural progenitor genes nestin, SOX2, and HNK1
were consistently expressed, other region specific markers
were differentially expressed over time. Because of this
heterogeneity, it is possible that the signal for lowly expressing
genes was below our level of detection. However, we interpret
this dynamic nature of gene expression within EZ spheres as a
contributing factor toward their diverse differentiation
potential, likely by allowing cells to effectively respond
to external differentiation cues even at later passages. As
such, when EZ spheres are removed from EGF and FGF-2
and placed into appropriate differentiation media, the
cells retain the capacity to up-regulate appropriate regional-
ization genes and consistently produce specified neurons and
Fig. 6 Dopamine (DA) neuron differentiation efficiency is
comparable between EZ spheres and EBs. (A) Following treatment
with FGF-8 and sonic hedgehog, H9 EZ spheres and H9 EBs
generated TH+ cells (red) that co-labeled with the neuronal
marker Tuj1 (green). Arrows indicate TH+/Tuj1+ cells; asterisks
indicate TH−/Tuj1+ cells. (B) Four weeks after directed differen-
tiation in the presence of FGF-8 and sonic hedgehog signaling,
there was no significant difference in the number of TH+/Tuj1+
neurons generated in H9 hESC EBs (EB-DA) and H9 hESC EZ spheres
(EZ-DA). H9 hESC EZ spheres do not generate TH positive neurons in
the absence of FGF-8 and sonic hedgehog signaling (EZ; ND=not
detected). ***pb0.0001.
426 A.D. Ebert et al.glia. Furthermore, terminal differentiation from EZ spheres
shows similar efficiencies compared to standard EB protocols.
Efficient neural differentiation has been described by
using dual SMAD inhibition during hESC and iPSC pattern-
ing (Chambers et al., 2009). Importantly, EZ spheres are
easily adaptable to this step as inhibitors to TGFβ, activin, and
BMP (e.g. noggin and SB431542) can be added directly to
floating EZ spheres at the start of the directed differentiation,
as was done for the sensory neuron differentiation (Fig. S3).
Although dual SMAD inhibition did not increase nestin
expression in early passage H9 hESC-derived EZ spheres (Fig.
S5), further optimization and increased yield of terminally
differentiated neural subtypes may be achieved by incorpo-
rating this in the EZ sphere differentiation protocols.
In summary, this simple protocol allows rapid expansion of
early multipotent stem cells that carry a pre-rosette identity
and retain the potential to producemany cell types of CNS and
PNS origin. Our established EZ sphere culture method mayhelp facilitate the wide range of clinical science applications
for hESC- and iPSC-derived neural tissue.
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.scr.2013.01.009.
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